Dry eye is a condition which is estimated to affect around 30 million Americans, and has traditionally been treated with eye drops or otherwise temporary solutions. Recently, it has been discovered that a condition called Meibomian Glad Dysfunction (MGD) is responsible for around 86% of dry eye cases, offering new insight into how to address the underlying problem.
Instead of adding moisture directly to the eyes, LipiFlow takes a different approach to dry eye and tackles the oils that buildup in the glands responsible for MGD. By clearing the buildup that blocks natural lubrication, LipiFlow works to address the root cause of dry eye and can work to return the eye to its natural, moisture-producing state. Upon completion of the LipiFlow treatment, patients can expect their eyes to begin producing natural oils again over the course of a couple days, and results typically last for about a year.
What To Expect
While there are multiple options for treating MGD and its symptoms, LipiFlow is the only treatment that has been approved by the FDA to remove blockages of the Meibomian glands. The treatment is always administered under supervision of an eye doctor, and is not painful. Our optometrist will apply an eyecup and lid warmer to your eyes, which use a combination of heat and pressure during the procedure. It takes less than 15 minutes at a time, and will enable your tear glands to again produce natural tears.